JOSEPH ELLUL: Open Payments
NPI 1881237485 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 9 payments from 5 companies in 2025. Trend: 2023 $422 · 2024 $209 · 2025 $255
Food & beverage: $232Education: $23
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $84 |
| Alnylam Pharmaceuticals Inc. | 3 | $73 |
| JAZZ PHARMACEUTICALS INC. | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Celgene Corporation | 1 | $21 |
Products named: TALVEY, AMVUTTRA, RYLAZE, REBLOZYL, DEFITELIO.
Industry payments across MI — which companies pay providers there.
